Viral protein-independent activation of the PAN promoter was also confirmed by the significant increase in luciferase activity in BJAB cells, a human B-cell lymphoma line without KSHV infection [25, 26], following treatment with the three compounds (Supplementary Figure 4). The gene discussed is ADA2; the disease is B-cell non-Hodgkin lymphoma.